Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential as ...
For pediatric patients with drug-resistant focal epilepsy, stereoelectroencephalography-guided radiofrequency ...
Background Cardiac sarcoidosis (CS) creates complex treatment challenges, especially for patients who fail to respond to ...
Lantheus Holdings, Inc. (NASDAQ:LNTH) is one of the best high growth healthcare stocks to buy now. On March 17, Jefferies ...
A small molecule inside your body quietly fuels life every day. It helps your cells turn fat into energy, keeping your heart ...
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...
Machine-learning physiologic signal model achieved 90% sensitivity and 99% negative predictive value for ischemia detection in symptomatic patients The model showed strong sensitivity in both ...
MRI offers the possibility of personalized neoadjuvant chemotherapy for patients with HER2-positive breast cancer, but it may not be ready for prime time.
Lumexa Imaging's advanced imaging volumes and mix are rising, driving superior unit economics and margin expansion. Read why LMRI stock is a Buy.
Among young adults with adrenal masses, 78% receive no hormonal evaluation, despite significant rates of malignancy and functional tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results